Skip to main navigation
Skip to search
Skip to main content
Scholars @ UT Health San Antonio Home
Help & FAQ
English
Español
Home
Profiles
Research units
Publications
Datasets
Search by expertise, name or affiliation
Glucocorticoids and immune checkpoint inhibitors in glioblastoma
William J. Kelly
, Mark R. Gilbert
Research output
:
Contribution to journal
›
Review article
›
peer-review
19
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Glucocorticoids and immune checkpoint inhibitors in glioblastoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Immune Checkpoint Inhibitor
100%
Glucocorticoid
50%
Glioblastoma
30%
Immunotherapy
30%
T Lymphocyte
20%
Combination Therapy
20%
Cancer
20%
Tumor Cell
10%
Immune System
10%
Patient Population
10%
Clinical Management
10%
Brain Cancer
10%
Development
10%
Central Nervous System Tumor
10%
Lymphocyte Function
10%
Survival
10%
Aptitude
10%
Character
10%
Patient
10%
Inpatient
10%
Cancer Treatment
10%
Immunology and Microbiology
Immunity
60%
Glucocorticoid
50%
Immunotherapy
30%
Central Nervous System
10%
Immune System
10%
Tumor Cell
10%
Lymphocyte Function
10%
Molecule
10%
Electric Potential
10%
Development
10%
Survival
10%
Character
10%
Aptitude
10%
Pharmacology, Toxicology and Pharmaceutical Science
Glucocorticoid
50%
Glioblastoma
30%
Immunotherapy
30%
Clinical Trial
20%
Brain Cancer
10%
Central Nervous System Tumor
10%
Survival
10%
Neuroscience
Immunotherapy
30%
Brain Tumor
10%